In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

about

Selection of PD1/PD-L1 X-Aptamers.

P2860

Q47799774-0F936E63-EEA9-470C-A457-F4522CD231B9

P2860

In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

Item

http://www.wikidata.org/entity/Q47930013

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

@en

In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

@nl

type

Item

label

In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

@en

In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

@nl

prefLabel

In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

@en

In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

@nl

P1476

In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

@en

P2093

Charles S Via

http://www.w3.org/2001/XMLSchema#string

Fred D Finkelman

http://www.w3.org/2001/XMLSchema#string

Irina Puliaeva

http://www.w3.org/2001/XMLSchema#string

Kateryna Soloviova

http://www.w3.org/2001/XMLSchema#string

Maksym Puliaiev

http://www.w3.org/2001/XMLSchema#string

Roman Puliav

http://www.w3.org/2001/XMLSchema#string

Suzanne C Morris

http://www.w3.org/2001/XMLSchema#string

P2860

Endogenously produced IL-4 nonredundantly stimulates CD8+ T cell proliferation.

Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells.

Advances in lupus stemming from the parent-into-F1 model

Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.

Donor CD8 T cells and IFN-gamma are critical for sex-based differences in donor CD4 T cell engraftment and lupus-like phenotype in short-term chronic graft-versus-host disease mice.

T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.

Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism

Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Down

In vivo maturation of allo-specific CD8 CTL and prevention of lupus-like graft-versus-host disease is critically dependent on T cell signaling through the TNF p75 receptor but not the TNF p55 receptor.

CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus.

P304

11-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLIM.2017.03.008

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28359782

http://www.w3.org/2001/XMLSchema#string

P932

5484589

http://www.w3.org/2001/XMLSchema#string

In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

about

P2860

P2860

In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932